1. Economic evaluation of nivolumab combined with ipilimumab in the first-line treatment of advanced melanoma in Japan. (1st December 2020) Authors: Paly, Victoria Federico; Hikichi, Yusuke; Baker, Timothy; Itakura, Eijun; Chandran, Nisha; Harrison, James Journal: Journal of medical economics Issue: Volume 23:Number 12(2021) Page Start: 1542 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Is Sentinel Node Susceptibility to Metastases Related to Nodal Immune Modulation?. Issue 1 (January 2015) Authors: Cochran, Alistair J.; Huang, Rong-Rong; Su, Albert; Itakura, Eijun; Wen, Duan-Ren Journal: Cancer journal Issue: Volume 21:Issue 1(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Japanese real‐world study of sequential nivolumab and ipilimumab treament in melanoma. Issue 11 (17th September 2019) Authors: Tsutsumida, Arata; Fukushima, Satoshi; Yokota, Kenji; Yoshikawa, Shusuke; Yamasaki, Osamu; Tanemura, Atsushi; Okuyama, Ryuhei; Uhara, Hisashi; Muto, Yusuke; Miyashita, Azusa; Akiyama, Masashi; Kaji, Tatsuya; Koga, Hiroshi; Kato, Junji; Katayama, Teruaki; Itakura, Eijun; Yamazaki, Naoya; Kiyohara,... Journal: Journal of dermatology Issue: Volume 46:Issue 11(2019) Page Start: 947 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Real‐world safety and efficacy data of ipilimumab in Japanese radically unresectable malignant melanoma patients: A postmarketing surveillance. Issue 8 (8th June 2020) Authors: Yamazaki, Naoya; Kiyohara, Yoshio; Uhara, Hisashi; Tsuchida, Tetsuya; Maruyama, Keiko; Shakunaga, Naoki; Itakura, Eijun; Komoto, Akira Journal: Journal of dermatology Issue: Volume 47:Issue 8(2020) Page Start: 834 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗